Stem Cells
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

First published online August 25, 2005
Stem Cells Vol. 24 No. 3 March 2006, pp. 557 -567
doi:10.1634/stemcells.2005-0233; www.StemCells.com
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2005-0233v1
2005-0233v2
24/3/557    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, D.-W.
Right arrow Articles by Kim, K.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, D.-W.
Right arrow Articles by Kim, K.-S.
EMBRYONIC STEM CELLS

Stromal Cell–Derived Inducing Activity, Nurr1, and Signaling Molecules Synergistically Induce Dopaminergic Neurons from Mouse Embryonic Stem Cells

Dong-Wook Kima,b,c, Sangmi Chunga,b, Mikyeong Hwanga,b, Andrew Ferreea,d, Hsing-Chen Tsaia,b, Jae-Joon Parka,b,c, Seungsoo Chungc, Taick Sang Namc, Un Jung Kange, Ole Isacsona,d, Kwang-Soo Kima,b

a Udall Parkinson’s Disease Research Center of Excellence;
b Molecular Neurobiology Laboratories; McLean Hospital/Harvard Medical School, Belmont, Massachusetts, USA;
c Department of Physiology, Yonsei University College of Medicine, Seoul, Korea;
d Neuroregeneration Laboratories; McLean Hospital/Harvard Medical School, Belmont, Massachusetts, USA;
e Departments of Neurology and Pharmacology, Physiology, and Neurobiology, The University of Chicago, Chicago, Illinois, USA

Key Words. Embryonic stem cells • Stromal cell-derived inducing activity • Nurr1 • Dopaminergic neurons Parkinson’s disease

Correspondence: Kwang-Soo Kim, Ph.D., MRC 216, McLean Hospital, Harvard Medical School, 115 Mill Street, Belmont, Massachusetts 02178, USA. Telephone: 617-855-2024; Fax: 617-855-3479; e-mail: kskim{at}mclean.harvard.edu

Received on March 11, 2005; accepted for publication on July 15, 2005.

To induce differentiation of embryonic stem cells (ESCs) into specialized cell types for therapeutic purposes, it may be desirable to combine genetic manipulation and appropriate differentiation signals. We studied the induction of dopaminergic (DA) neurons from mouse ESCs by overexpressing the transcription factor Nurr1 and coculturing with PA6 stromal cells. Nurr1-expressing ESCs (N2 and N5) differentiated into a higher number of neurons (~twofold) than the naïve ESCs (D3). In addition, N2/N5-derived cells contained a significantly higher proportion (>50%) of tyrosine hydroxylase (TH)+ neurons than D3 (<30%) and an even greater proportion of TH+ neurons (~90%) when treated with the signaling molecules sonic hedgehog, fibroblast growth factor 8, and ascorbic acid. N2/N5-derived cells express much higher levels of DA markers (e.g., TH, dopamine transporter, aromatic amino acid decarboxylase, and G protein–regulated inwardly rectifying K+ channel 2) and produce and release a higher level of dopamine, compared with D3-derived cells. Furthermore, the majority of generated neurons exhibited electrophysiological properties characteristic of midbrain DA neurons. Finally, transplantation experiments showed efficient in vivo integration/generation of TH+ neurons after implantation into mouse striatum. Taken together, our results show that the combination of genetic manipulation(s) and in vitro cell differentiation conditions offers a reliable and effective induction of DA neurons from ESCs and may pave the way for future cell transplantation therapy in Parkinson’s disease.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
K.-C. Hwang, J. Y. Kim, W. Chang, D.-S. Kim, S. Lim, S.-M. Kang, B.-W. Song, H.-Y. Ha, Y. J. Huh, I.-G. Choi, et al.
Chemicals that modulate stem cell differentiation
PNAS, May 27, 2008; 105(21): 7467 - 7471.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. S. Cho, Y.-E. Lee, J. Y. Kim, S. Chung, Y. H. Cho, D.-S. Kim, S.-M. Kang, H. Lee, M.-H. Kim, J.-H. Kim, et al.
Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells
PNAS, March 4, 2008; 105(9): 3392 - 3397.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
B. Coleman, M. G. de Silva, and R. K. Shepherd
Concise Review: The Potential of Stem Cells for Auditory Neuron Generation and Replacement
Stem Cells, November 1, 2007; 25(11): 2685 - 2694.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
J. A. Rodriguez-Gomez, J.-Q. Lu, I. Velasco, S. Rivera, S. S. Zoghbi, J.-S. Liow, J. L. Musachio, F. T. Chin, H. Toyama, J. Seidel, et al.
Persistent Dopamine Functions of Neurons Derived from Embryonic Stem Cells in a Rodent Model of Parkinson Disease
Stem Cells, April 1, 2007; 25(4): 918 - 928.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
S.-M. Kang, M. S. Cho, H. Seo, C. J. Yoon, S. K. Oh, Y. M. Choi, and D.-W. Kim
Efficient Induction of Oligodendrocytes from Human Embryonic Stem Cells
Stem Cells, February 1, 2007; 25(2): 419 - 424.
[Abstract] [Full Text] [PDF]

Home page
 Stem CellsHome page
L. Lin and O. Isacson
Axonal Growth Regulation of Fetal and Embryonic Stem Cell-Derived Dopaminergic Neurons by Netrin-1 and Slits
Stem Cells, November 1, 2006; 24(11): 2504 - 2513.
[Abstract] [Full Text] [PDF]

Home page
 Phil Trans R Soc BHome page
S. A Goldman and M. S Windrem
Cell replacement therapy in neurological disease
Phil Trans R Soc B, September 29, 2006; 361(1473): 1463 - 1475.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2006 by AlphaMed Press.